Skip to search formSkip to main contentSkip to account menu

HercepTest

An FDA approved test for the evaluation of HER2 protein overexpression in breast tumors. It provides semi-quantitative results of p185HER2 (HER2 gene… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Comparison of visual and automated assessment of HER2 status and their impact on outcome in primary operable invasive ductal breast cancer
Mohammed Z M A, Going J J, McMillan D C, Orange C, Mallon E, Doughty J C & Edwards J 
(2012) Histopathology 61, 675–684 
2012
2012
Approaching heterogeneity of human epidermal growth factor receptor 2 in surgical specimens of gastric cancer.
2012
2012
High concordance between HercepTest immunohistochemistry and ERBB2 fluorescence in situ hybridization before and after implementation of American Society of Clinical Oncology/College of American…
Human epidermal growth factor receptor 2 (HER2, ERBB2) is an important critical predictive marker in patients with invasive… 
Review
2010
Review
2010
Impact of American Society of Clinical Oncology/College of American Pathologists guideline recommendations on HER2 interpretation in breast cancer.
2007
2007
Comparison of immunohistochemical and fluorescence in situ hybridization assessment for HER-2/neu status in Taiwanese breast cancer patients.
2006
2006
Novel approach of human epidermal growth factor receptor 2 detection in noninvasive and invasive transitional cell carcinoma of the bladder.
2004
2004
The HercepTest and routine C-erbB2 immunohistochemistry in breast cancer: any difference?
INTRODUCTION The proto-oncogene c-erbB2, located on chromosome 17q21, encodes a 185-kD transmembrane glycoprotein. It is known to… 
Highly Cited
2002
Highly Cited
2002
Assessment of molecular markers of clinical sensitivity to single-agent taxane therapy for metastatic breast cancer.
PURPOSE The taxanes affect tubulin polymerization and interfere with mitotic transition. A checkpoint blockade at the G(1)-S… 
Highly Cited
2001
Highly Cited
2001
Herceptest: Her2 expression and gene amplification in non‐small cell lung cancer
HER2 is an erbB/HER type 1 tyrosine kinase receptor that is frequently over‐expressed in malignant epithelial tumours. Herceptin… 
Highly Cited
2001
Highly Cited
2001
Chromogenic in situ hybridization analysis of HER‐2/neu status in breast carcinoma: Application in screening of patients for trastuzumab (Herceptin®) therapy
Evaluation of HER‐2/neu status is important in the management of patients with breast carcinoma, especially in determining the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)